Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention
Image Truvada, made by Gilead Sciences, currently costs about $20,000 annually. The company has been under pressure to make the drug more widely available. CreditNicole Bengiveno/The New York Times Gilead Sciences, maker of Truvada, the only drug approved to prevent infection with H.I.V., will donate enough of the drug to supply 200,000 patients annually for up…